GlassScriptPhysician profile
Jacob Richard Battle
NPI 1477513190
$4,880.92
in general payments reported to CMS, 2019-2025
20 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,790 · 2021: $889 · 2022: $1,271 · 2023: $249 · 2024: $369 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913 · Entertainment: $17.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.13 |
| Entertainment | $17.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,465.19 | 2019-2021 | |
| Pylant Medical | $1,359.50 | 2022-2025 | |
| Medtronic, INC. | $216.93 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Primeadvanced Surescan |
| Stryker Corporation | $170.68 | 2019-2024 | Ortholoc 2 Lapifuse, 7 X 23mm Citrelock Implant |
| Boston Scientific Corporation | $146.28 | 2022-2024 | |
| Abbott Laboratories | $124.43 | 2022-2025 | Eterna, Proclaim, Octrode |
| Pacira Pharmaceuticals Incorporated | $121.81 | 2023-2025 | Exparel, Zilretta, Iovera |
| Novo Nordisk INC | $58.03 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $33.67 | 2025 | |
| Biotronik Nro, INC. | $25.99 | 2025 | Prospera |
| Edwards Lifesciences Corporation | $20.07 | 2022 | |
| Acclarent, INC | $19.81 | 2023 | Trudi Nav Cable |
| Optos, INC. | $17.18 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Pfizer INC. | $16.60 | 2023 | |
| Xeris Pharmaceuticals, INC. | $16.13 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.99 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $14.64 | 2021 | |
| Tactile Systems Technology INC | $13.64 | 2025 | Flexitouch Plus, Nimbl |
| Teva Pharmaceuticals USA, INC. | $12.71 | 2021 | |
| Heron Therapeutics, INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Battle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.